MBT
ABBV icon

Montecito Bank & Trust’s AbbVie ABBV Stock Holding History

Montecito Bank & Trust’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.42M Sell
29,468
-1,739
-6% -$374K 1.11% 22
2026
Q1 		$6.79M Sell
31,207
-532
-2% -$118K 1.12% 23
2025
Q4 		$7.25M Sell
31,739
-2,590
-8% -$590K 1.16% 21
2025
Q3 		$7.95M Buy
+34,329
New +$6.99M 1.23% 19
2025
Q1 		$6.87M Sell
32,789
-56
-0.2% -$10.9K 1.22% 21
2024
Q4 		$5.84M Sell
32,845
-230
-0.7% -$42.3K 1.01% 22
2024
Q3 		$6.53M Buy
33,075
+6,639
+25% +$1.24M 1.11% 21
2024
Q2 		$4.53M Sell
26,436
-376
-1% -$62.3K 0.92% 23
2024
Q1 		$4.88M Sell
26,812
-197
-0.7% -$34K 0.98% 23
2023
Q4 		$4.19M Sell
27,009
-2,596
-9% -$378K 0.9% 30
2023
Q3 		$4.41M Sell
29,605
-2,395
-7% -$352K 1.03% 24
2023
Q2 		$4.31M Sell
32,000
-717
-2% -$105K 0.98% 24
2023
Q1 		$5.21M Sell
32,717
-1,564
-5% -$239K 1.24% 19
2022
Q4 		$5.54M Sell
34,281
-569
-2% -$87.2K 1.34% 17
2022
Q3 		$4.68M Sell
34,850
-1,941
-5% -$279K 1.22% 20
2022
Q2 		$5.63M Sell
36,791
-13,160
-26% -$2.01M 1.34% 18
2022
Q1 		$8.1M Sell
49,951
-795
-2% -$115K 1.52% 14
2021
Q4 		$6.87M Buy
50,746
+860
+2% +$102K 1.22% 22
2021
Q3 		$5.38M Buy
49,886
+411
+0.8% +$47K 1.05% 27
2021
Q2 		$5.57M Buy
49,475
+320
+0.7% +$36K 1.07% 26
2021
Q1 		$5.32M Sell
49,155
-2,011
-4% -$215K 1.1% 24
2020
Q4 		$5.48M Buy
51,166
+1,694
+3% +$163K 1.2% 22
2020
Q3 		$4.33M Buy
49,472
+3,800
+8% +$358K 1.1% 22
2020
Q2 		$4.48M Buy
45,672
+4,975
+12% +$438K 1.23% 19
2020
Q1 		$3.1M Buy
40,697
+7,574
+23% +$645K 1.02% 24
2019
Q4 		$2.93M Buy
33,123
+15,529
+88% +$1.29M 0.79% 31
2019
Q3 		$1.33M Sell
17,594
-482
-3% -$33K 0.4% 59
2019
Q2 		$1.31M Sell
18,076
-126
-0.7% -$9.9K 0.4% 61
2019
Q1 		$1.47M Sell
18,202
-1,411
-7% -$115K 0.45% 57
2018
Q4 		$1.81M Buy
19,613
+398
+2% +$35K 0.62% 39
2018
Q3 		$1.82M Buy
19,215
+1,845
+11% +$175K 0.54% 43
2018
Q2 		$1.61M Sell
17,370
-606
-3% -$59.2K 0.52% 40
2018
Q1 		$1.7M Buy
17,976
+3,433
+24% +$377K 0.56% 41
2017
Q4 		$1.41M Buy
14,543
+454
+3% +$42.8K 0.46% 42
2017
Q3 		$1.25M Sell
14,089
-93
-0.7% -$7.08K 0.43% 43
2017
Q2 		$1.03M Buy
+14,182
New +$953K 0.37% 52
2017
Q1 		– Sell
-11,029
Closed -$690K – 187
2016
Q4 		$690K Buy
11,029
+829
+8% +$50.6K 0.24% 79
2016
Q3 		$644K Buy
10,200
+400
+4% +$25.9K 0.26% 82
2016
Q2 		$607K Buy
9,800
+650
+7% +$39.6K 0.26% 83
2016
Q1 		$523K Hold
9,150
– – 0.24% 78
2015
Q4 		$542K Sell
9,150
-3,750
-29% -$216K 0.26% 73
2015
Q3 		$702K Buy
12,900
+1,170
+10% +$76.2K 0.39% 52
2015
Q2 		$687K Hold
11,730
– – 0.34% 62
2015
Q1 		$687K Sell
11,730
-1,337
-10% -$80.8K 0.34% 62
2014
Q4 		$855K Buy
13,067
+1,190
+10% +$75K 0.45% 50
2014
Q3 		$686K Hold
11,877
– – 0.42% 54
2014
Q2 		$670K Sell
11,877
-231
-2% -$12.1K 0.4% 53
2014
Q1 		$622K Buy
12,108
+1,025
+9% +$51.8K 0.39% 55
2013
Q4 		$585K Sell
11,083
-200
-2% -$9.83K 0.37% 58
2013
Q3 		$505K Sell
11,283
-80
-0.7% -$3.55K 0.34% 63
2013
Q2 		$470K Buy
+11,363
New +$497K 0.32% 68

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Montecito Bank & Trust's ABBV Position: Q2 2026 in Review

Montecito Bank & Trust reduced its AbbVie (ABBV) stake by 5.6% in Q2 2026, selling an estimated $374K and leaving 29,468 shares worth $7.42M. The position accounts for 1.11% of the portfolio, ranked #22.

Montecito Bank & Trust first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.1M in Q1 2022. 921 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Montecito Bank & Trust held 29,468 shares of AbbVie worth $7.42M as of Q2 2026.
  • Montecito Bank & Trust sold 1,739 AbbVie shares in Q2 2026, an estimated $374K.
  • AbbVie made up 1.11% of Montecito Bank & Trust's portfolio in Q2 2026, its #22 holding.
  • Montecito Bank & Trust first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
  • Montecito Bank & Trust's AbbVie position peaked at $8.1M in Q1 2022.
  • 921 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Montecito Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.